GAMMA Investing’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,080
Closed -$516K 4159
2025
Q4
$516K Buy
5,080
+1,033
+26% +$83K 0.03% 523
2025
Q3
$221K Sell
4,047
-370
-8% -$18.5K 0.01% 912
2025
Q2
$235K Buy
4,417
+174
+4% +$8.84K 0.01% 814
2025
Q1
$184K Buy
4,243
+569
+15% +$28.8K 0.01% 806
2024
Q4
$206K Buy
3,674
+828
+29% +$51.5K 0.02% 675
2024
Q3
$194K Buy
2,846
+1,484
+109% +$83.8K 0.02% 641
2024
Q2
$57.5K Buy
1,362
+444
+48% +$24.4K 0.01% 1094
2024
Q1
$63.4K Sell
918
-207
-18% -$13.1K 0.01% 882
2023
Q4
$73.6K Buy
+1,125
New +$73.7K 0.02% 694

Other funds holding EXAS

GAMMA Investing's EXAS Position: Q1 2026 in Review

GAMMA Investing sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,080 shares — an estimated $516K sold.

GAMMA Investing first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $516K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • GAMMA Investing reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • GAMMA Investing sold 5,080 Exact Sciences shares in Q1 2026, an estimated $516K.
  • GAMMA Investing first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • GAMMA Investing's Exact Sciences position peaked at $516K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.